Neurodegenerative Diseases

"Neurodegenerative Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.

Descriptor ID	D019636
MeSH Number(s)	C10.574
Concept/Terms	Neurodegenerative Diseases Neurodegenerative Diseases Neurodegenerative Disease Degenerative Diseases, Neurologic Neurologic Degenerative Disease Degenerative Neurologic Diseases Degenerative Neurologic Disease Neurologic Disease, Degenerative Neurologic Diseases, Degenerative Nervous System Degenerative Diseases Neurodegenerative Disorders Neurodegenerative Disorder Neurologic Degenerative Conditions Degenerative Condition, Neurologic Degenerative Conditions, Neurologic Neurologic Degenerative Condition Neurologic Degenerative Diseases Degenerative Diseases, Nervous System Degenerative Neurologic Disorders Degenerative Neurologic Disorder Neurologic Disorder, Degenerative Neurologic Disorders, Degenerative Degenerative Diseases, Spinal Cord Degenerative Diseases, Spinal Cord Degenerative Diseases, Central Nervous System Degenerative Diseases, Central Nervous System

Below are MeSH descriptors whose meaning is more general than "Neurodegenerative Diseases".

Diseases [C]
Nervous System Diseases [C10]
Neurodegenerative Diseases [C10.574]

Below are MeSH descriptors whose meaning is related to "Neurodegenerative Diseases".

Below are MeSH descriptors whose meaning is more specific than "Neurodegenerative Diseases".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Neurodegenerative Diseases" by people in this website by year, and whether "Neurodegenerative Diseases" was a major or minor topic of these publications.

Bar chart showing 61 publications over 20 distinct years, with a maximum of 7 publications in 2013

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2003	3	0	3
2004	2	2	4
2005	0	1	1
2006	2	1	3
2007	1	1	2
2008	3	1	4
2009	2	0	2
2010	4	1	5
2011	1	0	1
2012	1	0	1
2013	5	2	7
2014	3	0	3
2015	4	2	6
2016	0	2	2
2017	5	0	5
2018	1	2	3
2019	1	2	3
2020	2	0	2
2021	3	0	3
2022	1	0	1

Below are the most recent publications written about "Neurodegenerative Diseases" by people in Profiles.

Haque A, Das A, Samantaray S, Matzelle D, Capone M, Wallace G, Husarik AN, Taheri S, Reiter RJ, Varma A, Ray SK, Banik NL. Premarin Reduces Neurodegeneration and Promotes Improvement of Function in an Animal Model of Spinal Cord Injury. Int J Mol Sci. 2022 Feb 21; 23(4).

View in: PubMed
Fucic A, Duca RC, Galea KS, Maric T, Garcia K, Bloom MS, Andersen HR, Vena JE. Reproductive Health Risks Associated with Occupational and Environmental Exposure to Pesticides. Int J Environ Res Public Health. 2021 06 18; 18(12).

View in: PubMed
Ammal Kaidery N, Ahuja M, Sharma SM, Thomas B. An Emerging Role of miRNAs in Neurodegenerative Diseases: Mechanisms and Perspectives on miR146a. Antioxid Redox Signal. 2021 09 01; 35(7):580-594.

View in: PubMed
Yin S, Liu L, Gan W. The Roles of Post-Translational Modifications on mTOR Signaling. Int J Mol Sci. 2021 Feb 11; 22(4).

View in: PubMed
Vizcarra JC, Gearing M, Keiser MJ, Glass JD, Dugger BN, Gutman DA. Validation of machine learning models to detect amyloid pathologies across institutions. Acta Neuropathol Commun. 2020 04 28; 8(1):59.

View in: PubMed
Rozpedek-Kaminska W, Siwecka N, Wawrzynkiewicz A, Wojtczak R, Pytel D, Diehl JA, Majsterek I. The PERK-Dependent Molecular Mechanisms as a Novel Therapeutic Target for Neurodegenerative Diseases. Int J Mol Sci. 2020 Mar 19; 21(6).

View in: PubMed
Cortes-Canteli M, Kruyer A, Fernandez-Nueda I, Marcos-Diaz A, Ceron C, Richards AT, Jno-Charles OC, Rodriguez I, Callejas S, Norris EH, Sanchez-Gonzalez J, Ruiz-Cabello J, Ibanez B, Strickland S, Fuster V. Long-Term Dabigatran Treatment Delays Alzheimer's Disease Pathogenesis in the TgCRND8 Mouse Model. J Am Coll Cardiol. 2019 10 15; 74(15):1910-1923.

View in: PubMed
Basak J, Rozpedek W, Pytel D, Majsterek I. Potential therapeutic application of PERK inhibitors Postepy Biochem. 2019 06 06; 65(2):118-127.

View in: PubMed
Hirose T, Cabrera-Socorro A, Chitayat D, Lemonnier T, Féraud O, Cifuentes-Diaz C, Gervasi N, Mombereau C, Ghosh T, Stoica L, Bacha JDA, Yamada H, Lauterbach MA, Guillon M, Kaneko K, Norris JW, Siriwardena K, Blasér S, Teillon J, Mendoza-Londono R, Russeau M, Hadoux J, Ito S, Corvol P, Matheus MG, Holden KR, Takei K, Emiliani V, Bennaceur-Griscelli A, Schwartz CE, Nguyen G, Groszer M. ATP6AP2 variant impairs CNS development and neuronal survival to cause fulminant neurodegeneration. J Clin Invest. 2019 04 15; 129(5):2145-2162.

View in: PubMed
Grames MS, Dayton RD, Jackson KL, Richard AD, Lu X, Klein RL. Cre-dependent AAV vectors for highly targeted expression of disease-related proteins and neurodegeneration in the substantia nigra. FASEB J. 2018 08; 32(8):4420-4427.

View in: PubMed

People

Explore

Similar Concepts

Top Journals